• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.56% Nasdaq Down 0.79%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    0.44 Down 0.03(5.86%) May 4, 4:00PM EDT
    |After Hours : 0.44 Up 0.01 (1.15%) May 4, 4:52PM EDT
    Prev Close:0.46
    Open:0.47
    Bid:0.41 x 2500
    Ask:0.48 x 9900
    1y Target Est:1.52
    Beta:2.34155
    Next Earnings Date:N/A
    Day's Range:0.42 - 0.47
    52wk Range:0.39 - 6.96
    Volume:2,750,676
    Avg Vol (3m):2,417,250
    Market Cap:63.32M
    P/E (ttm):N/A
    EPS (ttm):-0.52
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    ┬╗ More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREXDown 5.86%63.32M
    GSKDown 1.83%102.49B
    ABTDown 1.17%55.99B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.75
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.52
    Quarterly EPS Est (Jun-16) :-0.11
    Mean Recommendation*:3.1
    PEG Ratio (5 yr expected):0.01

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products. The company offers Contrave for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback